SCHEMBL6890858

SCHEMBL6890858

CC(O)C(N)C(NCCOc1ccccc1)c1ccccc1

nearest known ligand 0.51

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
SIGMAR1 Q99720 1/20 0.50
HTR1B P28222 2/20 0.45
HTR1D P28221 1/20 0.45
MTNR1A P48039 1/20 0.43
MTNR1B P49286 1/20 0.43
ADRA1D P25100 2/20 0.43
ADRA1A P35348 2/20 0.43
ADRA1B P35368 2/20 0.43
HTR1A P08908 1/20 0.43
HTR7 P34969 6/20 0.43
L3MBTL1 Q9Y468 1/20 0.42
DRD2 P14416 1/20 0.41
DRD4 P21917 1/20 0.41
DRD3 P35462 1/20 0.41
LMNA P02545 1/20 0.41
ADRB2 P07550 1/20 0.41
ADRB1 P08588 1/20 0.41
CYP2D6 P10635 1/20 0.41
ADRB3 P13945 1/20 0.41
ALDH1A1 P00352 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6895074 0.86 HPGD (0.44) LMNAALDH1A1
SCHEMBL6896045 0.83 ALDH1A1 (0.49) LMNAALDH1A1NPSR1GAA
SCHEMBL6890899 0.82 AOC3 (0.36) LMNAALDH1A1NPSR1
SCHEMBL6894568 0.80 CYP3A4 (0.44) ADRA1AHTR1ADRD2DRD3LMNA
SCHEMBL6889436 0.78 SIGMAR1 (0.49) SIGMAR1ADRA1AHTR1ALMNAADRB2
SCHEMBL6891363 0.76 KMT2A (0.55) SIGMAR1ADRB2ADRB3ALDH1A1GAA
SCHEMBL6894924 0.76 KDM4E (0.43) L3MBTL1LMNAALDH1A1
SCHEMBL6895263 0.76 KDM4E (0.43) L3MBTL1LMNACYP2D6ALDH1A1
SCHEMBL6887458 0.76 SIGMAR1 (0.51) SIGMAR1CYP2D6
SCHEMBL10990052 0.76 SIGMAR1 (0.61) SIGMAR1HTR1BHTR1DADRA1DADRA1A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
JP-2004502669-A 2004-01-29 JP claimed
EP-1353898-A2 COMPOUNDS TO TREAT ALZHEIMER'S DISEASE Elan Pharmaceuticals, Inc. (US) 2003-10-22 EP claimed
WO-2002002512-A2 COMPOUNDS TO TREAT ALZHEIMER'S DISEASE ELAN PHARMACEUTICALS, INC. (US) 2002-01-10 WO claimed